It is often well-tolerated in moderate doses but may have a mild laxative effect, which could be problematic for GLP-1 users already experiencing diarrhea or gastrointestinal upset
Patents cover coformulations with SGLT2 inhibitors, thyroid hormone receptor beta agonists, and other metabolic targets [25, 26], mirroring the scientific literature's growing focus on GLP-1's effects across MASH, cardiovascular disease, and other obesity-related conditions [27, 28]
GLP-1s often work better for both goals
Once constructed, the library could be easily screened with radioactive probes to identify specific genes It did not take long for Goodman to find the gene for somatostatin in his library (Bagley)
How do weight-loss drugs change taste
Finally, timing your semaglutide injection and meals strategically can help manage side effects